Berkshire Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.41M | Sell |
26,738
-498
| -2% | -$178K | 0.4% | 52 |
|
|
2025
Q4 | $8.91M | Buy |
27,236
+356
| +1% | +$113K | 0.39% | 54 |
|
|
2025
Q3 | $7.59M | Sell |
26,880
-649
| -2% | -$188K | 0.32% | 59 |
|
|
2025
Q2 | $7.69M | Sell |
27,529
-402
| -1% | -$114K | 0.35% | 57 |
|
|
2025
Q1 | $7.6M | Sell |
27,931
-690
| -2% | -$204K | 0.36% | 57 |
|
|
2024
Q4 | $7.88M | Sell |
28,621
-853
| -3% | -$253K | 0.37% | 54 |
|
|
2024
Q3 | $9.21M | Hold |
29,474
| – | – | 0.47% | 49 |
|
|
2024
Q2 | $9.21M | Buy |
29,474
+35
| +0.1% | +$10.3K | 0.46% | 50 |
|
|
2024
Q1 | $8.37M | Sell |
29,439
-236
| -0.8% | -$69.1K | 0.44% | 49 |
|
|
2023
Q4 | $8.55M | Sell |
29,675
-197
| -0.7% | -$53.7K | 0.49% | 49 |
|
|
2023
Q3 | $8.03M | Sell |
29,872
-360
| -1% | -$89.8K | 0.5% | 48 |
|
|
2023
Q2 | $6.71M | Buy |
30,232
+465
| +2% | +$108K | 0.4% | 51 |
|
|
2023
Q1 | $7.2M | Sell |
29,767
-231
| -0.8% | -$56.7K | 0.44% | 51 |
|
|
2022
Q4 | $7.88M | Sell |
29,998
-202
| -0.7% | -$54.1K | 0.51% | 48 |
|
|
2022
Q3 | $6.81M | Sell |
30,200
-86,263
| -74% | -$20.9M | 0.48% | 47 |
|
|
2022
Q2 | $28.3M | Buy |
116,463
+1,890
| +2% | +$463K | 1.85% | 24 |
|
|
2022
Q1 | $27.7M | Buy |
114,573
+2,731
| +2% | +$627K | 1.75% | 26 |
|
|
2021
Q4 | $25.2M | Sell |
111,842
-1,710
| -2% | -$361K | 1.53% | 27 |
|
|
2021
Q3 | $24.1M | Buy |
113,552
+1,125
| +1% | +$259K | 1.62% | 25 |
|
|
2021
Q2 | $27.4M | Buy |
112,427
+4,700
| +4% | +$1.16M | 1.85% | 19 |
|
|
2021
Q1 | $26.8M | Sell |
107,727
-6,193
| -5% | -$1.48M | 1.99% | 16 |
|
|
2020
Q4 | $26.2M | Buy |
113,920
+8,779
| +8% | +$2.02M | 2.01% | 18 |
|
|
2020
Q3 | $26.7M | Sell |
105,141
-7,441
| -7% | -$1.84M | 2.58% | 11 |
|
|
2020
Q2 | $26.6M | Sell |
112,582
-1,598
| -1% | -$365K | 2.44% | 10 |
|
|
2020
Q1 | $23.1M | Buy |
114,180
+4,537
| +4% | +$991K | 2.41% | 9 |
|
|
2019
Q4 | $26.4M | Sell |
109,643
-3,545
| -3% | -$781K | 2.25% | 12 |
|
|
2019
Q3 | $21.9M | Sell |
113,188
-16,627
| -13% | -$3.19M | 1.89% | 26 |
|
|
2019
Q2 | $23.9M | Buy |
129,815
+53
| +0% | +$9.49K | 1.98% | 15 |
|
|
2019
Q1 | $24.7M | Buy |
129,762
+73
| +0.1% | +$13.9K | 2.09% | 10 |
|
|
2018
Q4 | $25.2M | Buy |
129,689
+769
| +0.6% | +$150K | 2.36% | 9 |
|
|
2018
Q3 | $26.7M | Buy |
128,920
+5,490
| +4% | +$1.08M | 2.26% | 9 |
|
|
2018
Q2 | $22.8M | Sell |
123,430
-6,038
| -5% | -$1.07M | 2.13% | 14 |
|
|
2018
Q1 | $22.1M | Buy |
129,468
+1,595
| +1% | +$293K | 2.14% | 12 |
|
|
2017
Q4 | $22.2M | Buy |
127,873
+10,162
| +9% | +$1.8M | 2.16% | 13 |
|
|
2017
Q3 | $21.9M | Sell |
117,711
-1,490
| -1% | -$264K | 2.45% | 10 |
|
|
2017
Q2 | $20.5M | Buy |
119,201
+3,364
| +3% | +$547K | 2.34% | 11 |
|
|
2017
Q1 | $19M | Buy |
115,837
+4,409
| +4% | +$733K | 2.26% | 13 |
|
|
2016
Q4 | $16.3M | Buy |
111,428
+33,368
| +43% | +$5.02M | 2.1% | 15 |
|
|
2016
Q3 | $13M | Buy |
78,060
+3,951
| +5% | +$668K | 1.87% | 18 |
|
|
2016
Q2 | $11.3M | Sell |
74,109
-11,952
| -14% | -$1.86M | 1.72% | 20 |
|
|
2016
Q1 | $12.9M | Buy |
86,061
+2,931
| +4% | +$435K | 2.01% | 17 |
|
|
2015
Q4 | $13.5M | Buy |
83,130
+4,757
| +6% | +$748K | 2.23% | 14 |
|
|
2015
Q3 | $10.8M | Buy |
78,373
+2,563
| +3% | +$404K | 1.93% | 17 |
|
|
2015
Q2 | $11.6M | Buy |
75,810
+612
| +0.8% | +$98K | 1.96% | 14 |
|
|
2015
Q1 | $12M | Buy |
75,198
+1,128
| +2% | +$178K | 2.01% | 14 |
|
|
2014
Q4 | $11.8M | Sell |
74,070
-1,003
| -1% | -$156K | 2.03% | 17 |
|
|
2014
Q3 | $10.5M | Buy |
75,073
+307
| +0.4% | +$40.1K | 1.94% | 17 |
|
|
2014
Q2 | $8.85M | Buy |
+74,766
| New | +$8.65M | 1.64% | 21 |
|
|
2014
Q1 | – | Sell |
-9,050
| Closed | -$1.03M | – | 157 |
|
|
2013
Q4 | $1.03M | Buy |
9,050
+400
| +5% | +$45.5K | 0.19% | 82 |
|
|
2013
Q3 | $968K | Buy |
+8,650
| New | +$938K | 0.23% | 79 |
|
Other funds holding AMGN
VCM
VPM
Berkshire Asset Management's AMGN Position: Q1 2026 in Review
Berkshire Asset Management reduced its Amgen (AMGN) stake by 1.8% in Q1 2026, selling an estimated $178K and leaving 26,738 shares worth $9.41M. The position accounts for 0.4% of the portfolio, ranked #52.
Berkshire Asset Management first reported a position in AMGN in Q3 2013 and has held it in 50 quarters since. The position peaked at $28.3M in Q2 2022. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Berkshire Asset Management held 26,738 shares of Amgen worth $9.41M as of Q1 2026.
- Berkshire Asset Management sold 498 Amgen shares in Q1 2026, an estimated $178K.
- Amgen made up 0.4% of Berkshire Asset Management's portfolio in Q1 2026, its #52 holding.
- Berkshire Asset Management first reported a position in Amgen in Q3 2013 and has held it in 50 quarters since.
- Berkshire Asset Management's Amgen position peaked at $28.3M in Q2 2022.
- 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Berkshire Asset Management's 13F filing for Q1 2026, filed 11 May 2026.